Evaxion Biotech

FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy
Pharmaceutical Business Review
Fri, 01/20/23 - 10:26 am
Evaxion Biotech
EVX-01
FDA
fast track
personalized medicine
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Merck
Keytruda
Xeris Biopharma
XeriJect
Evaxion Biotech
EVX-01
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan